May 10, 2017
Icare USA, a subsidiary of Icare Finland, announced that the Icare Home tonometer has been cleared by the FDA, and is now available for use in the U.S.
The Icare Home provides eyecare professionals with clinical data about how their patients’ IOP fluctuates throughout the day. Instead of using a puff of air, the device uses the same patented rebound technology other Icare tonometers, such as the ic100 and the TA01i. No eye drops are required, and patients do not need specialized skills to use it.
“The fact that we can put a tonometer of this caliber in the hands of patients is truly unprecedented,” says John Floyd, president and CEO of Icare USA. “The Icare Home makes doctors aware of dangerous spikes that they may never have known about otherwise. The impact and level of care that this provides cannot be overstated.”
Several features make the Icare Home easy for patients to use. For instance, the unit’s built-in Icare EyeSmart technology performs automatic OD/OS recognition. Positioning is also easy thanks to Icare EasyPos, which uses red and green light signals to help patients correctly position the tonometer. The Icare Home also features Icare AMS, an automated measuring sequence that can take either a single measurement or a series of six measurements with one touch of a button.
For more information, visit www.icare-usa.com or call (888) 422-7313
